These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23405989)

  • 1. Serum biomarker analysis of collagen disease patients with acute-onset diffuse interstitial lung disease.
    Oka S; Furukawa H; Shimada K; Hayakawa H; Fukui N; Tsuchiya N; Tohma S
    BMC Immunol; 2013 Feb; 14():9. PubMed ID: 23405989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis.
    Furukawa H; Oka S; Higuchi T; Shimada K; Hashimoto A; Matsui T; Tohma S
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211022506. PubMed ID: 34211592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Metabolomic Profiles of Rheumatoid Arthritis Patients With Acute-Onset Diffuse Interstitial Lung Disease.
    Furukawa H; Oka S; Shimada K; Hashimoto A; Komiya A; Matsui T; Fukui N; Tohma S
    Biomark Insights; 2019; 14():1177271919870472. PubMed ID: 31488947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The serum levels of cytokines in patients with rheumatoid arthritis associated interstitial lung disease and their clinical significance].
    Ji YX; Huang JA; Zong JP; Lü DF; Xin XF; He J; Chen Y; Chen XH; Yu SP; Li JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):264-7. PubMed ID: 18846962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Deleterious Rare Alleles for Acute-Onset Diffuse Interstitial Lung Disease in Collagen Diseases.
    Furukawa H; Oka S; Shimada K; Hashimoto A; Komiya A; Matsui T; Tohma S
    Clin Med Insights Circ Respir Pulm Med; 2019; 13():1179548419866443. PubMed ID: 31391785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody Profiles in Collagen Disease Patients with Interstitial Lung Disease (ILD): Antibodies to Major Histocompatibility Complex Class I-Related Chain A (MICA) as Markers of ILD.
    Furukawa H; Oka S; Shimada K; Masuo K; Nakajima F; Funano S; Tanaka Y; Komiya A; Fukui N; Sawasaki T; Tadokoro K; Nose M; Tsuchiya N; Tohma S
    Biomark Insights; 2015; 10():63-73. PubMed ID: 26327779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum stratifin measurement is useful for evaluating disease severity and outcomes in patients with acute exacerbation of interstitial lung disease: a retrospective study.
    Sakuma N; Abe M; Ishii D; Kawasaki T; Arakawa N; Matsuyama S; Saito Y; Suzuki T; Tatsumi K
    BMC Pulm Med; 2024 Jul; 24(1):364. PubMed ID: 39075455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.
    Kass DJ; Nouraie M; Glassberg MK; Ramreddy N; Fernandez K; Harlow L; Zhang Y; Chen J; Kerr GS; Reimold AM; England BR; Mikuls TR; Gibson KF; Dellaripa PF; Rosas IO; Oddis CV; Ascherman DP
    Arthritis Rheumatol; 2020 Mar; 72(3):409-419. PubMed ID: 31532072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study.
    Shen H; Xia L; Lu J
    Indian J Med Res; 2013 Dec; 138(6):919-21. PubMed ID: 24521636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of interleukins and S100A8/A9 correlate with clinical severity in patients with dermatomyositis-associated interstitial lung disease.
    Lou Y; Zheng Y; Fan B; Zhang L; Zhu F; Wang X; Chen Z; Tan X; Wei Q
    BMC Pulm Med; 2020 Jul; 20(1):196. PubMed ID: 32680574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
    Doyle TJ; Patel AS; Hatabu H; Nishino M; Wu G; Osorio JC; Golzarri MF; Traslosheros A; Chu SG; Frits ML; Iannaccone CK; Koontz D; Fuhrman C; Weinblatt ME; El-Chemaly SY; Washko GR; Hunninghake GM; Choi AM; Dellaripa PF; Oddis CV; Shadick NA; Ascherman DP; Rosas IO
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1403-12. PubMed ID: 25822095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study.
    Matsuo T; Hashimoto M; Ito I; Kubo T; Uozumi R; Furu M; Ito H; Fujii T; Tanaka M; Terao C; Kono H; Mori M; Hamaguchi M; Yamamoto W; Ohmura K; Morita S; Mimori T
    Scand J Rheumatol; 2019 Mar; 48(2):87-94. PubMed ID: 30269670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serum level and significance of lysyl oxidase-like 2 in patients with rheumatoid arthritis-associated interstitial lung disease.
    Fu Q; Bai Y; Liu Y; Zhou J; Zheng Y
    Clin Rheumatol; 2018 Jan; 37(1):193-198. PubMed ID: 29052023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis.
    Just SA; Lindegaard H; Hejbøl EK; Davidsen JR; Bjerring N; Hansen SWK; Schrøder HD; Hansen IMJ; Barington T; Nielsen C
    Respir Res; 2017 Jul; 18(1):141. PubMed ID: 28720095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchoalveolar matrix metalloproteinase 9 relates to restrictive lung function impairment in systemic sclerosis.
    Andersen GN; Nilsson K; Pourazar J; Hackett TL; Kazzam E; Blomberg A; Waldenström A; Warner J; Rantapää-Dahlqvist S; Mincheva-Nilsson L; Sandström T
    Respir Med; 2007 Oct; 101(10):2199-206. PubMed ID: 17643278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study.
    Kameda H; Tokuda H; Sakai F; Johkoh T; Mori S; Yoshida Y; Takayanagi N; Taki H; Hasegawa Y; Hatta K; Yamanaka H; Dohi M; Hashimoto S; Yamada H; Kawai S; Takeuchi T; Tateda K; Goto H
    Intern Med; 2011; 50(4):305-13. PubMed ID: 21325762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
    Rheumatology (Oxford); 2002 Jan; 41(1):78-87. PubMed ID: 11792884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis.
    Xiangyang Z; Lutian Y; Lin Z; Liping X; Hui S; Jing L
    Cytokine; 2012 Apr; 58(1):6-9. PubMed ID: 22239947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory biomarkers in saliva and serum of patients with rheumatoid arthritis with respect to periodontal status.
    Äyräväinen L; Heikkinen AM; Kuuliala A; Ahola K; Koivuniemi R; Laasonen L; Moilanen E; Hämäläinen M; Tervahartiala T; Meurman JH; Leirisalo-Repo M; Sorsa T
    Ann Med; 2018 Jun; 50(4):333-344. PubMed ID: 29683364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.